Private Advisor Group’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,885
Closed -$198K 2619
2025
Q2
$198K Buy
5,885
+700
+14% +$22.2K ﹤0.01% 2239
2025
Q1
$165K Buy
5,185
+647
+14% +$24.6K ﹤0.01% 2134
2024
Q4
$176K Buy
4,538
+144
+3% +$6.05K ﹤0.01% 2112
2024
Q3
$198K Buy
4,394
+55
+1% +$2.46K ﹤0.01% 2228
2024
Q2
$181K Sell
4,339
-287
-6% -$12K ﹤0.01% 2173
2024
Q1
$211K Sell
4,626
-824
-15% -$37.5K ﹤0.01% 2082
2023
Q4
$252K Sell
5,450
-139,030
-96% -$5.67M ﹤0.01% 1898
2023
Q3
$5.88M Sell
144,480
-99,723
-41% -$4.54M 0.05% 345
2023
Q2
$11.8M Sell
244,203
-9,571
-4% -$479K 0.1% 194
2023
Q1
$12.5M Sell
253,774
-14,540
-5% -$748K 0.12% 176
2022
Q4
$188K Sell
268,314
-33,688
-11% -$1.74M 0.01% 896
2022
Q3
$15.2M Buy
302,002
+7,284
+2% +$411K 0.17% 123
2022
Q2
$14.4M Buy
294,718
+86,271
+41% +$4.37M 0.13% 164
2022
Q1
$12.5M Buy
208,447
+38,250
+22% +$2.41M 0.1% 203
2021
Q4
$13.5M Buy
170,197
+37,172
+28% +$3.12M 0.1% 200
2021
Q3
$11.8M Buy
133,025
+95,881
+258% +$8.98M 0.07% 263
2021
Q2
$3.7M Buy
+37,144
New +$3.29M 0.03% 509

Other funds holding GNOM

Private Advisor Group's GNOM Position: Q3 2025 in Review

Private Advisor Group sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2025, closing a stake of 5,885 shares — an estimated $198K sold.

Private Advisor Group first reported a position in GNOM in Q2 2021 and held it in 17 quarters. The position peaked at $15.2M in Q3 2022. 41 funds tracked by Wall St. Rank hold GNOM as of Q3 2025.

  • Private Advisor Group reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Private Advisor Group sold 5,885 Global X Genomics & Biotechnology ETF shares in Q3 2025, an estimated $198K.
  • Private Advisor Group first reported a position in Global X Genomics & Biotechnology ETF in Q2 2021 and held it in 17 quarters.
  • Private Advisor Group's Global X Genomics & Biotechnology ETF position peaked at $15.2M in Q3 2022.
  • 41 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2025.

Based on Private Advisor Group's 13F filing for Q3 2025, filed 13 Nov 2025.